Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Chan Lin

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Scientific Reports|November 10, 2017
ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLATChen-Yuan Lin, Chia-Fong Cho, Shih-Ting Bai, et al.
Anticancer Research|December 16, 2014
Safety and efficacy of pegylated liposomal doxorubicin-based adjuvant chemotherapy in patients with stage I-III triple-negative breast cancerMing-Yu Lien, Liang-Chih Liu, Hwei-Chung Wang, et al.
Leukemia Research|January 2, 2013
Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3Po-Han Lin, Ching-Chan Lin, Hwai-I Yang, et al.
Cancers|July 14, 2023
Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone-A Retrospective StudyHao Xiang Chen, Li-Hsien Tsai, Chao-Hsiang Chang, et al.
Cancer Medicine|January 11, 2017
A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practicePo-Han Lin, Huei-Ying Li, Sheng-Chih Fan, et al.
Nature Cancer|January 24, 2024
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapyYu-Kai Huang, Wei-Chung Cheng, Ting-Ting Kuo, et al.
Theranostics|October 12, 2020
Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progressionChing-Chan Lin, Yu-Kai Huang, Chia-Fong Cho, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Scientific Reports|November 10, 2017
ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLATChen-Yuan Lin, Chia-Fong Cho, Shih-Ting Bai, et al.
Anticancer Research|December 16, 2014
Safety and efficacy of pegylated liposomal doxorubicin-based adjuvant chemotherapy in patients with stage I-III triple-negative breast cancerMing-Yu Lien, Liang-Chih Liu, Hwei-Chung Wang, et al.
Leukemia Research|January 2, 2013
Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3Po-Han Lin, Ching-Chan Lin, Hwai-I Yang, et al.
Cancers|July 14, 2023
Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone-A Retrospective StudyHao Xiang Chen, Li-Hsien Tsai, Chao-Hsiang Chang, et al.
Cancer Medicine|January 11, 2017
A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practicePo-Han Lin, Huei-Ying Li, Sheng-Chih Fan, et al.
Nature Cancer|January 24, 2024
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapyYu-Kai Huang, Wei-Chung Cheng, Ting-Ting Kuo, et al.
Theranostics|October 12, 2020
Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progressionChing-Chan Lin, Yu-Kai Huang, Chia-Fong Cho, et al.
Pageof 4